Viewing Study NCT01598103


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2025-12-29 @ 5:01 AM
Study NCT ID: NCT01598103
Status: TERMINATED
Last Update Posted: 2020-12-19
First Post: 2012-02-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module